Calendar

««Sep 2008»»
SMTWTFS
 
1
2
3
4
5
6
7
8910111213
14151617181920
21222324252627
282930
  More

Search Box

 

Mailing List

RSS Feeds








Add to Jamespot
Widgetize!

Translate



Link to Ai profile Link to Anxiety Community Link to Wellsphere

Health Wisdom

HealthCentral Top Site Award

IBS Tales Hope Award

Disclaimer

All content within Anxiety Insights is provided for general information only, and should not be treated as a substitute for the medical advice of your doctor or other health care professional.

Anxiety Insights is not responsible or liable for any diagnosis made by a reader based on the content of this website.

Anxiety Insights is not liable for the contents of any external internet sites listed, nor does it endorse any commercial product or service mentioned or advised on any of the sites.

Always consult your doctor if you are in any way concerned about your health.

recommended links

Depression is Real's Down & Up Show
      Weekly audio-casts from the
      Depression Is Real Coalition

we support

Kiva.org - micro loans that change lives

Moving a Nation to Care : Post Traumatic Stress Disorder and America's Returning Troops, by Ilona Meagher

No Longer Lonely.com

"just don't smoke"


"Don't smoke, whatever you do, just don't smoke."
                        Yul Brynner

Hit Counter

Total: 1,692,697
since: 14 May 2006

Abstract: Effects of timing and duration of gestational exposure to SSRIs

posted Thursday, 1 May 2008

Br J Psychiatry. 2008 May 1; 192:338-343

Effects of timing and duration of gestational exposure to serotonin reuptake inhibitor antidepressants: population-based study

Oberlander TF, Warburton W, Misri S, Aghajanian J.

Human Early Learning Partnership, University of British Columbia, Vancouver, British Columbia, Canada

Background: Late-gestational serotonin reuptake inhibitor (SRI) exposure has been linked to adverse neonatal outcomes; however, the impact of timing and duration of exposure is unknown.

Aims: To determine whether late-gestational exposure to an SRI is associated with increased risk of adverse neonatal outcome relative to early exposure.

Method: Population-based maternal and neonatal health records were linked to prenatal maternal prescription records for an SRI medication (n=3500).

Results: After controlling for maternal illness and duration of exposure, using propensity score matching, neonatal outcomes did not differ between late and early exposure (P>0.05). After controlling for maternal illness, longer prenatal exposure increased the risks of lower birth weight, respiratory distress and reduced gestational age (P<0.05).

Conclusions: Using population health data, length of gestational SRI exposure, rather than timing, increased the risk for neonatal respiratory distress, lower birth weight and reduced gestational age, even when controlling for maternal illness and medication dose. These findings highlight the importance of distinguishing the specific impact of medication exposure from exposure to maternal illness itself.

Source...

Comment:  
While all medications should be avoided during pregnancy if possible, there can be adverse consequences to both the fetus and mother if antidepressants from untreated depression and psychological stress.[1, 2, 3] Obstetricians need to work with the patient's mental health care provider (preferably a psychiatrist) to ensure the best outcome for both mother and child.

tags:      

links: digg this    del.icio.us    technorati    reddit